The Peter Attia Drive - #391 ‒ Colorectal cancer screening: importance of early screening, colonoscopy as a screening and preventive tool, and how to build a personalized strategy

Episode Date: May 11, 2026

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this episode, Peter takes a deep dive into colorectal cancer (CRC) screening, explaining why it is one of the most preventable cancers and why getting screening right can have life-saving implications. He walks through how colorectal cancer develops and why it is uniquely well-suited to early detection and prevention, with a particular emphasis on the dual role of colonoscopy as both a diagnostic and therapeutic tool. Peter also examines the concerning rise in early-onset CRC among younger adults, highlighting why awareness and timely screening matter more than ever. The episode provides a practical guide to preparing for and evaluating the quality of a colonoscopy, including how to think about appropriate screening intervals and the real risks and tradeoffs involved. Finally, Peter explores the expanding landscape of non-invasive screening options, offering clear insight into what these alternatives can and cannot do so listeners can make informed decisions about their care at any age. We discuss: CRC statistics and goals for this episode [1:00]; Colorectal cancer development: polyp progression, risk types, and the window for prevention [4:00]; Why colorectal cancer is uniquely screenable: direct visualization and the dual role of colonoscopy [6:30]; Colonoscopy effectiveness: prevention through polyp removal and interpreting the NordICC trial data [8:15]; Rising colorectal cancer in younger adults: trends, possible causes, and the case for earlier screening [12:15]; Colonoscopy preparation: why bowel prep matters and how newer options improve the experience [16:45]; Colonoscopy quality, polyp miss rates, and personalized screening intervals [20:00]; Colonoscopy risks versus colorectal cancer risk: understanding the true risk-benefit tradeoff [29:30]; Non-invasive screening options for CRC: benefits, limitations, and their role alongside colonoscopy [37:00]; Colorectal cancer prevention principles: why screening matters and the role of colonoscopy [39:30]; and More. Connect With Peter on Twitter, Instagram, Facebook and YouTube

Hey everyone, welcome to a sneak peek episode of The Drive podcast. I'm your host, Peter Attia. At the end of this short episode, I'll explain how you can access the episodes in full, along with a ton of other membership benefits we've created. Or you can learn more now by going to peteratia-md.com forward slash subscribe. So without further delay, here's today's sneak peek of the episode. Welcome to a new episode of The Drive. In today's episode, I'm diving into colorectal cancer screening. Why colorectal cancer is one of the most preventable cancers we know of and why getting screening

right matters so much. In this episode, I'm going to discuss many things, but among them how colorectal cancer develops. Why colonoscopy is uniquely valuable as both a screening and preventive tool, the troubling rise in early onset colorectal cancer, and how to think clearly about the growing menu of non-invasive screening. options and their limitations. If you're not a subscriber, you'll only be able to listen to a sneak peek here. So without further delay, I hope you'll enjoy today's episode of The Drive. Colorectal cancer, or CRC, as we'll abbreviate it, is the second leading cause of cancer

death in the United States. And it's projected to be responsible for roughly 55,000 deaths this year. according to the American Cancer Society. That puts it behind only lung cancer as far as cancer mortality. And yet, unlike many other cancers, CRC is arguably the most preventable cancer we know of. And the reason for this is that CRC follows a well-characterized, slow progression from completely normal tissue to a benign polyp to a pre-cancerous polyp to frank malignancy. And that progression almost always takes years, often a decade or more. And because the colon is a hollow organ and sits outside the body, as crazy as that sounds,

we can directly access and visualize it. We have the ability to not only detect those precancerous lesions, but also remove them before they ever become cancer. So no other common cancer screening test can make that claim. A mammogram can detect breast cancer, a low-dose CT scan can detect lung cancer, but neither of those are able to look directly at the cancer. And so a colonoscopy can not only do that, but it can also remove the precancerous lesion in the first place. And yet a 2020 CDC estimate claims that 68% of colorectal cancer deaths may be prevented with screening, even at the traditional recommended interval. Again, that statistic should stop you cold. We're talking about a cancer that in most cases gives us a decades-long window to intervene,

and we're still losing nearly 70% of people out of that 55,000 deaths a year because they never walked through the front door to get a colonoscopy. Even more, I would argue that this number could be closer to 100%, i.e., 100% reduction in colorectal cancer death with more aggressive screening protocols, including starting earlier and screening more often. So today I want to cover this topic comprehensively. We'll start with the basic biology of colorectal cancer and why it's uniquely suited to screening. Then we'll talk about the rise of early onset colorectal cancer in younger adults.

From there, we'll go into the colonoscopy itself, how to prepare for one, how to ensure you're getting a high-quality exam, and how to think about screening intervals. We'll discuss real risks and tradeoffs and finally we'll walk through the growing landscape of non-invasive screening alternatives, both stool-based tests and blood-based tests, and talk about what they can and can't do. The goal here is to leave you with a very clear, practical picture of colorectal cancer screening, whether you're 35 and wondering when to start or 55 and wondering when your coliagard test is good enough. Thank you for listening to today's sneak peek episode of The Drive. If you're interested in any of your carlager, hearing the complete version of you'll want to become a premium member. It's extremely important to me to provide all of this content without relying on paid ads. To do this, our work is made entirely possible by our members, and in return, we offer exclusive member-only content and benefits

above and beyond what is available for free. So if you want to take your knowledge of this space to the next level, it's our goal to ensure members get back much more than the price of the subscription. Premium membership includes several benefits. First, comprehensive, comprehensive podcast show notes that detail every topic, paper, person, and thing that we discuss in each episode. And the word on the street is nobody's show notes rival ours. Second, monthly Ask Me Anything or AMA episodes. These episodes are comprised of detailed responses to subscriber questions, typically focused on a single topic and are designed to offer a great deal of clarity and detail on topics of special interest to our members.

You'll also get access to the show notes for these episodes, of course. Third, delivery of our premium newsletter, which is put together by our dedicated team of research analysts. This newsletter covers a wide range of topics related to longevity and provides much more detail than our free weekly newsletter. Fourth, access to our private podcast feed that provides you with access to every episode, including AMAs, Sons the Spiel you're listening to now, and in your regular podcast feed. Fifth, the Qualies, an additional member-only podcast we put together that serves as a highlight reel featuring the best excerpts from previous episodes of the drive. This is a great way to catch up on previous episodes without having to go back and listen to each one of them.

And finally, other benefits that are added along the way. If you want to learn more and access these member-only benefits, you can head over to peteratia-md.com forward slash subscribe. You can also find me on YouTube, Instagram, and Twitter. Twitter, all with the handle Peter Attia MD. You can also leave us review on Apple Podcasts or whatever podcast player you use. This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing, or other professional healthcare services, including the giving of medical

advice. No doctor-patient relationship is formed. The use of this information and the materials linked to this podcast is at the user's own risk. The content on this podcast is not intended to be. a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice from any medical condition they have, and they should seek the assistance of their healthcare professionals for any such conditions. Finally, I take all conflicts of interest

very seriously. For all of my disclosures and the companies I invest in or advise, please visit peteratia-md.com forward slash about where I keep an up-to-date and active list of all disclosures. Thank you.